2020

06

• Selected as a tenant company of Korea University Crimson Start-up Support Foundation BI

• Established ‘einocle’

• Organized a consortium for the comprehensive research on the immune system of patients infected with COVID-19
  – Collaboration between BD Global Grant, Chungnam National University Hospital, Samsung Medical Center, Asan Medical Center, and KAIST 

09

• Established einocle Research Center

• Moved to Korea University Future Technology Development Center (Research & Business Foundation, Techno Complex)

10

• Certified as a small business

12

• Attained Pre-series A investment

2021

02-05

• Attained Pre-series A investment
• Attracted investment from Korea University Holdings

07

• Selected as TIPS R&D national project
  700 million KRW for 2 years

09

• Established non-small cell lung cancer single-cell multi-omics research consortium
  – Collaboration between BD Global Grant, Severance Hospital, Yonsei University 

11

• einocle – Signed MOU with KIST Europe
  – Business agreement for joint research and support for entering the global market

2022

01

• Certified as a venture company 

02

• Attained Pre-series A investment

04

• Developed a patent for COVID-19 triage and monitoring method 

08

• KU Tech-Fair for CES 2023 Excellence Award
  Confirmed participation in CES2023 with full sponsorship 

• Certificate of Corporate Research Institute

• Single Cell Analysis System Patent Application

2023

01

• Participation in CES 2023 with SOLGARAM^TM 

02

• Participation in Global Acceleration Silicon Valley Program (GASP)
  – Participation in the global advancement support program for Promising Startups
  – Network formation with KU Global Center in Silicon Valley, USA

03

• Paper published on single-cell transcriptomic analysis of immune system and anti-inflammatory mechanism of corticosteroid in large-scale COVID-19 patients

10

• signed MOU with ReDGene
  – Agreement for business exchange and joint research

2023

07

• Selection of Institutions for the Project Supported by the Ministry of Trade, Industry and Energy: ‘Development of Material-Component Based Technologies and Immunotherapy Application Technologies to Secure Competitiveness in the Spatial Omics Industry. (Total Government R&D Fund: 18.1 billion KRW)

10

• Signed MOU with SEASUN BIOMATERIALS
  – Agreement for business exchange and joint R&D for the development of a Next-generation precision medicine system